| 1 | Opportunities to encourage adoption of a biomarker-enabled care pathway for Alzheimer's in primary care | 1.5 | 5 | Citations (PDF) |
| 2 | Characterization of human cytomegalovirus infection dynamics in human microglia | 1.9 | 1 | Citations (PDF) |
| 3 | Real-world implications of the prospects for prevention of clinical Alzheimer's dementia | 0.2 | 1 | Citations (PDF) |
| 4 | Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease | 0.9 | 75 | Citations (PDF) |
| 5 | Alzheimer’s Disease Aβ-Amyloid Plaque Morphology Varies According to APOE Isotype () | 0.1 | 1 | Citations (PDF) |
| 6 | Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer’s disease | 11.0 | 119 | Citations (PDF) |
| 7 | New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia | 0.9 | 46 | Citations (PDF) |
| 8 | A Letter Concerning “Aducanumab: What about the Patient?” | 4.7 | 4 | Citations (PDF) |
| 9 | Reduced cerebellar cortical thickness in World Trade Center responders with cognitive impairment | 3.9 | 18 | Citations (PDF) |
| 10 | Log in to my account | 1.7 | 44 | Citations (PDF) |
| 11 | World Trade Center dust induces nasal and neurological tissue injury while propagating reduced olfaction capabilities and increased anxiety behaviors | 1.1 | 9 | Citations (PDF) |
| 12 | Microglial TYROBP/DAP12 in Alzheimer’s disease: Transduction of physiological and pathological signals across TREM2 | 9.8 | 161 | Citations (PDF) |
| 13 | The Golgi apparatus: Site for convergence of COVID-19 brain fog and Alzheimer’s disease? | 9.8 | 10 | Citations (PDF) |
| 14 | Transformative Network Modeling of Multi-omics Data Reveals Detailed Circuits, Key Regulators, and Potential Therapeutics for Alzheimer’s DiseaseNeuron, 2021, 109, 257-272.e14 | 8.7 | 183 | Citations (PDF) |
| 15 | Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP–APOE link in wild-type and Alzheimer's-related mice | 0.9 | 67 | Citations (PDF) |
| 16 | Molecular subtyping of Alzheimer’s disease using RNA sequencing data reveals novel mechanisms and targets | 8.2 | 297 | Citations (PDF) |
| 17 | Selective hippocampal subfield volume reductions in World Trade Center responders with cognitive impairment | 1.5 | 16 | Citations (PDF) |
| 18 | A cortical thinning signature to identify World Trade Center responders with possible dementia | 1.2 | 11 | Citations (PDF) |
| 19 | Laterality and region-specific tau phosphorylation correlate with PTSD-related behavioral traits in rats exposed to repetitive low-level blast | 3.4 | 16 | Citations (PDF) |
| 20 | Log in to my account | 1.7 | 11 | Citations (PDF) |
| 21 | Progressive Cognitive and Post-Traumatic Stress Disorder-Related Behavioral Traits in Rats Exposed to Repetitive Low-Level Blast | 2.4 | 31 | Citations (PDF) |
| 22 | Repetitive Low-Level Blast Exposure Improves Behavioral Deficits and Chronically Lowers Aβ42 in an Alzheimer Disease Transgenic Mouse Model | 2.4 | 15 | Citations (PDF) |
| 23 | A Workshop on Cognitive Aging and Impairment in the 9/11-Exposed Population | 2.0 | 12 | Citations (PDF) |
| 24 | Low-level blast exposure induces chronic vascular remodeling, perivascular astrocytic degeneration and vascular-associated neuroinflammation | 3.4 | 50 | Citations (PDF) |
| 25 | Genome-wide association study and functional validation implicates JADE1 in tauopathy | 6.0 | 35 | Citations (PDF) |
| 26 | Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA | 9.8 | 11 | Citations (PDF) |
| 27 | Cortical complexity in world trade center responders with chronic posttraumatic stress disorder | 3.9 | 24 | Citations (PDF) |
| 28 | Cognitive impairment and World Trade Centre-related exposures | 18.0 | 54 | Citations (PDF) |
| 29 | Transcranial Laser Therapy Does Not Improve Cognitive and Post-Traumatic Stress Disorder–Related Behavioral Traits in Rats Exposed to Repetitive Low-Level Blast Injury | 0.9 | 3 | Citations (PDF) |
| 30 | Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions | 4.6 | 111 | Citations (PDF) |
| 31 | miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease | 6.0 | 37 | Citations (PDF) |
| 32 | Multiscale causal networks identify VGF as a key regulator of Alzheimer’s disease | 11.0 | 177 | Citations (PDF) |
| 33 | Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife | 2.5 | 22 | Citations (PDF) |
| 34 | Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure | 5.6 | 89 | Citations (PDF) |
| 35 | VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice | 9.8 | 89 | Citations (PDF) |
| 36 | Comparison of brain connectomes by MRI and genomics and its implication in Alzheimer’s disease | 4.4 | 12 | Citations (PDF) |
| 37 | Incidence of mild cognitive impairment in World Trade Center responders: Long-term consequences of re-experiencing the events on 9/11/2001 | 1.5 | 66 | Citations (PDF) |
| 38 | Low-level blast exposure disrupts gliovascular and neurovascular connections and induces a chronic vascular pathology in rat brain | 3.4 | 97 | Citations (PDF) |
| 39 | Relationship of traumatic brain injury to chronic mental health problems and dementia in military veterans | 1.3 | 70 | Citations (PDF) |
| 40 | Posttraumatic stress disorder and total amyloid burden and amyloid-β 42/40 ratios in plasma: Results from a pilot study of World Trade Center responders | 1.5 | 30 | Citations (PDF) |
| 41 | Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's disease | 2.8 | 8 | Citations (PDF) |
| 42 | Clarifying the Potential Role of Microbes in Alzheimer’s Disease | 8.7 | 13 | Citations (PDF) |
| 43 | Blast-induced "PTSD": Evidence from an animal model | 3.1 | 41 | Citations (PDF) |
| 44 | Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums | 18.0 | 1,524 | Citations (PDF) |
| 45 | Integrated biology approach reveals molecular and pathological interactions among Alzheimer’s Aβ42, Tau, TREM2, and TYROBP in Drosophila models | 5.9 | 35 | Citations (PDF) |
| 46 | Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus | 8.7 | 728 | Citations (PDF) |
| 47 | Parahippocampal gyrus expression of endothelial and insulin receptor signaling pathway genes is modulated by Alzheimer’s disease and normalized by treatment with anti-diabetic agents | 1.5 | 28 | Citations (PDF) |
| 48 | iPSC-derived familial Alzheimer’s PSEN2 N141I cholinergic neurons exhibit mutation-dependent molecular pathology corrected by insulin signaling | 9.8 | 45 | Citations (PDF) |
| 49 | Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden | 5.6 | 88 | Citations (PDF) |
| 50 | Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau | 5.6 | 65 | Citations (PDF) |
| 51 | PTSD-Related Behavioral Traits in a Rat Model of Blast-Induced mTBI Are Reversed by the mGluR2/3 Receptor Antagonist BCI-838ENeuro, 2018, 5, ENEURO.0357-17.2018 | 1.2 | 58 | Citations (PDF) |
| 52 | Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology | 6.0 | 121 | Citations (PDF) |
| 53 | Military Blast Injury and Chronic Neurodegeneration: Research Presentations from the 2015 International State-of-the-Science Meeting | 2.4 | 16 | Citations (PDF) |
| 54 | CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2 N141I neurons | 3.4 | 151 | Citations (PDF) |
| 55 | Midlife interventions are critical in prevention, delay, or improvement of Alzheimer’s disease and vascular cognitive impairment and dementia | 0.3 | 16 | Citations (PDF) |
| 56 | Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction | 0.3 | 80 | Citations (PDF) |
| 57 | Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer’s APP/PSEN1 mice by gene targeting of diabetes/Alzheimer’s-related Sorcs1 | 3.4 | 26 | Citations (PDF) |
| 58 | Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes | 3.8 | 46 | Citations (PDF) |
| 59 | Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer’s disease | 5.9 | 303 | Citations (PDF) |
| 60 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | 12.0 | 5,058 | Citations (PDF) |
| 61 | Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels | 0.9 | 100 | Citations (PDF) |
| 62 | “White Paper” meeting summary and catalyst for future inquiry: Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction | 0.3 | 73 | Citations (PDF) |
| 63 | Mind the gaps—advancing research into short-term and long-term neuropsychological outcomes of youth sports-related concussions | 18.0 | 74 | Citations (PDF) |
| 64 | Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer’s disease pathogenesis | 5.3 | 141 | Citations (PDF) |
| 65 | Physiologically generated presenilin 1 lacking exon 8 fails to rescue brain PS1−/− phenotype and forms complexes with wildtype PS1 and nicastrin | 2.7 | 5 | Citations (PDF) |
| 66 | Characterization and Molecular Profiling of PSEN1 Familial Alzheimer's Disease iPSC-Derived Neural Progenitors | 1.5 | 163 | Citations (PDF) |
| 67 | Chronic traumatic encephalopathy: clinical‐biomarker correlations and current concepts in pathogenesis | 9.8 | 62 | Citations (PDF) |
| 68 | Pentameric Thiophene-Based Ligands that Spectrally Discriminate Amyloid-β and Tau Aggregates Display Distinct Solvatochromism and Viscosity-Induced Spectral Shifts | 2.4 | 51 | Citations (PDF) |
| 69 | Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model | 1.3 | 45 | Citations (PDF) |
| 70 | Dystonia type 6 gene product Thap1: identification of a 50 kDa DNA-binding species in neuronal nuclear fractions | 3.4 | 11 | Citations (PDF) |
| 71 | A consecutive case series experience with [18 F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition | 9.8 | 32 | Citations (PDF) |
| 72 | Alzheimer’s Disease: New Data Highlight Nonneuronal Cell Types and the Necessity for Presymptomatic Prevention Strategies | 4.3 | 12 | Citations (PDF) |
| 73 | [18F]-T807 tauopathy PET imaging in chronic traumatic encephalopathy | 0.3 | 30 | Citations (PDF) |
| 74 | Florbetapir F18 Positron Emission Tomography Identification of beta-Amyloid in the Living Brain: A Consecutive Clinical Case Series (P6.319) | 0.7 | 0 | Citations (PDF) |
| 75 | CR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease. | 4.3 | 22 | Citations (PDF) |
| 76 | Toward the Treatment and Prevention of Alzheimer's Disease: Rational Strategies and Recent Progress | 10.4 | 99 | Citations (PDF) |
| 77 | Protein Sorting Motifs in the Cytoplasmic Tail of SorCS1 Control Generation of Alzheimer's Amyloid-β Peptide | 2.3 | 40 | Citations (PDF) |
| 78 | Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers | 18.0 | 258 | Citations (PDF) |
| 79 | Vps10 Family Proteins and the Retromer Complex in Aging-Related Neurodegeneration and Diabetes | 2.3 | 74 | Citations (PDF) |
| 80 | Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease | 4.4 | 17 | Citations (PDF) |
| 81 | Multiple γ-secretase product peptides are coordinately increased in concentration in the cerebrospinal fluid of a subpopulation of sporadic Alzheimer’s disease subjects | 9.8 | 15 | Citations (PDF) |
| 82 | Top bar navigation | 1.6 | 39 | Citations (PDF) |
| 83 | Rapid doubling of Alzheimer’s amyloid-β40 and 42 levels in brains of mice exposed to a nickel nanoparticle model of air pollution | 0.3 | 64 | Citations (PDF) |
| 84 | Rapid doubling of Alzheimer’s amyloid-β40 and 42 levels in brains of mice exposed to a nickel nanoparticle model of air pollution | 0.3 | 0 | Citations (PDF) |
| 85 | Review: Contact sport-related chronic traumatic encephalopathy in the elderly: clinical expression and structural substrates | 1.9 | 92 | Citations (PDF) |
| 86 | Coordinated increase of γ-secretase reaction products in the plasma of some female Japanese sporadic Alzheimer's disease patients: quantitative analysis of p3-Alcα with a new ELISA system | 9.8 | 12 | Citations (PDF) |
| 87 | Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and alzheimer's disease: Evidence for γ-secretase dysfunction | 4.7 | 42 | Citations (PDF) |
| 88 | Perspective: Prevention is better than cure | 31.8 | 55 | Citations (PDF) |
| 89 | Amyloid-β Oligomers: Possible Roles as Key Neurotoxins in Alzheimer's Disease | 1.8 | 119 | Citations (PDF) |
| 90 | Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-β oligomers | 4.7 | 144 | Citations (PDF) |
| 91 | Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated | 9.8 | 141 | Citations (PDF) |
| 92 | Protein kinase C and rho activated coiled coil protein kinase 2 (ROCK2) modulate Alzheimer's APP metabolism and phosphorylation of the Vps10-domain protein, SorL1 | 9.8 | 20 | Citations (PDF) |
| 93 | Traumatic Brain Injury — Football, Warfare, and Long-Term Effects | 24.4 | 301 | Citations (PDF) |
| 94 | Log in to my account | 1.7 | 62 | Citations (PDF) |
| 95 | Alcadein Cleavages by Amyloid β-Precursor Protein (APP) α- and γ-Secretases Generate Small Peptides, p3-Alcs, Indicating Alzheimer Disease-related γ-Secretase Dysfunction* | 1.3 | 52 | Citations (PDF) |
| 96 | APOE ε4 and bapineuzumabInfusing pharmacogenomics into Alzheimer disease therapeutics | 0.7 | 22 | Citations (PDF) |
| 97 | Dietary composition modulates brain mass and solubilizable Aβ levels in a mouse model of aggressive Alzheimer's amyloid pathology | 9.8 | 47 | Citations (PDF) |
| 98 | Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo | 9.8 | 41 | Citations (PDF) |
| 99 | Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia | 11.5 | 419 | Citations (PDF) |
| 100 | Enhanced generation of Alzheimer's amyloid-beta following chronic exposure to phorbol ester correlates with differential effects on alpha and epsilon isozymes of protein kinase C. | 2.7 | 32 | Citations (PDF) |
| 101 | Phosphorylation of the amino-terminal region of X11L regulates its interaction with APP. | 2.7 | 14 | Citations (PDF) |
| 102 | Novel Pentameric Thiophene Derivatives for in Vitro and in Vivo Optical Imaging of a Plethora of Protein Aggregates in Cerebral Amyloidoses | 2.5 | 327 | Citations (PDF) |
| 103 | Mutant Presenilin 1 Increases the Levels of Alzheimer Amyloid β-Peptide Aβ42 in Late Compartments of the Constitutive Secretory Pathway | 2.7 | 14 | Citations (PDF) |
| 104 | Regulation of Forkhead Transcription Factor FoxO3a Contributes to Calorie Restriction-induced Prevention of Alzheimer's Disease-type Amyloid Neuropathology and Spatial Memory Deterioration | 2.6 | 118 | Citations (PDF) |
| 105 | X11 Proteins Regulate the Translocation of Amyloid β-Protein Precursor (APP) into Detergent-resistant Membrane and Suppress the Amyloidogenic Cleavage of APP by β-Site-cleaving Enzyme in Brain* | 1.3 | 64 | Citations (PDF) |
| 106 | Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology | 0.7 | 153 | Citations (PDF) |
| 107 | Evidence against roles for phorbol binding protein Munc13-1, ADAM adaptor Eve-1, or vesicle trafficking phosphoproteins Munc18 or NSF as phospho-state-sensitive modulators of phorbol/PKC-activated Alzheimer APP ectodomain shedding | 9.8 | 17 | Citations (PDF) |
| 108 | Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo. | 2.7 | 26 | Citations (PDF) |
| 109 | Brain neprilysin activity and susceptibility to transgene-induced Alzheimer amyloidosis | 1.3 | 25 | Citations (PDF) |
| 110 | Sorting through the Cell Biology of Alzheimer's Disease: Intracellular Pathways to Pathogenesis | 8.7 | 319 | Citations (PDF) |
| 111 | Physiological Mouse Brain Aβ Levels Are Not Related to the Phosphorylation State of Threonine-668 of Alzheimer's APP | 1.5 | 61 | Citations (PDF) |
| 112 | Alzheimer's amyloid immunotherapy: quo vadis? | 24.0 | 13 | Citations (PDF) |
| 113 | Modulation of Statin-Activated Shedding of Alzheimer APP Ectodomain by ROCK | 4.2 | 142 | Citations (PDF) |
| 114 | Breaking Up (Amyloid) Is Hard to Do | 4.2 | 6 | Citations (PDF) |
| 115 | The role of cerebral amyloid β accumulation in common forms of Alzheimer disease | 6.8 | 249 | Citations (PDF) |
| 116 | The role of cerebral amyloid accumulation in common forms of Alzheimer disease | 6.8 | 262 | Citations (PDF) |
| 117 | Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding. | 2.7 | 69 | Citations (PDF) |
| 118 | Toward modeling hemorrhagic and encephalitic complications of Alzheimer amyloid-β vaccination in nonhuman primates | 3.7 | 29 | Citations (PDF) |
| 119 | Similar promotion of Aβ1-42 fibrillogenesis by native apolipoprotein E ε3 and ε4 isoforms | 6.2 | 5 | Citations (PDF) |
| 120 | Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage | 3.0 | 71 | Citations (PDF) |
| 121 | Letters to the editor | 1.5 | 0 | Citations (PDF) |
| 122 | Current Concepts and Future Prospects for Alzheimer Disease Vaccines | 0.9 | 27 | Citations (PDF) |
| 123 | Estrogen and Neurodegeneration | 2.8 | 51 | Citations (PDF) |
| 124 | Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription | 2.7 | 210 | Citations (PDF) |
| 125 | Molecular and Cellular Basis for Anti-Amyloid Therapy in Alzheimer Disease | 0.9 | 42 | Citations (PDF) |
| 126 | Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer’s disease | 2.5 | 38 | Citations (PDF) |
| 127 | Human Cerebrospinal Fluid Apolipoprotein E Isoforms are Apparently Inefficient at Complexing with Synthetic Alzheimer’s Amyloid-β Peptide (Aß1−40) in vitro | 4.4 | 6 | Citations (PDF) |
| 128 | The Phosphatidylinositol 3-Kinase Inhibitor Wortmannin Alters the Metabolism of the Alzheimer's Amyloid Precursor Protein | 2.7 | 52 | Citations (PDF) |
| 129 | Molecular consequences of presenilin-1 mutation | 31.8 | 22 | Citations (PDF) |
| 130 | Regulation of Alzheimer β-amyloid precursor trafficking and metabolism | 2.8 | 36 | Citations (PDF) |
| 131 | Phylogenetically conserved CK-II phosphorylation site of the murine homeodomain protein Hoxb-6 | 2.1 | 13 | Citations (PDF) |
| 132 | Generation of the Amyloid-β Peptide N Terminus inSaccharomyces cerevisiae Expressing Human Alzheimer's Amyloid-β Precursor Protein* | 1.3 | 18 | Citations (PDF) |
| 133 | Neurohormonal Signaling Pathways and the Regulation of Alzheimer β-Amyloid Precursor Metabolism | 10.9 | 36 | Citations (PDF) |
| 134 | Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides | 25.8 | 572 | Citations (PDF) |
| 135 | Involvement of Cell Surface Glycosyl-phosphatidylinositol-linked Aspartyl Proteases in α-Secretase-type Cleavage and Ectodomain Solubilization of Human Alzheimer β-Amyloid Precursor Protein in Yeast* | 1.3 | 60 | Citations (PDF) |
| 136 | Generation and Regulation of β-Amyloid Peptide Variants by Neurons | 2.7 | 114 | Citations (PDF) |
| 137 | Apolipoprotein E ∈4 Associated With Chronic Traumatic Brain Injury in Boxing | 19.5 | 439 | Citations (PDF) |
| 138 | Generation of Alzheimer β-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation | 5.3 | 281 | Citations (PDF) |
| 139 | Increased apolipoprotein E ϵ4 in epilepsy with senile plaques | 4.7 | 93 | Citations (PDF) |
| 140 | Apolipoprotein E, Aβ-Amyloid, and the Molecular Pathology of Alzheimer's Disease Therapeutic Implicationsa | 2.6 | 12 | Citations (PDF) |
| 141 | The National Institute on Aging/Alzheimer's Association Recommendations on the Application of Apolipoprotein E Genotyping to Alzheimer's Diseasea | 2.6 | 71 | Citations (PDF) |
| 142 | Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients | 3.8 | 60 | Citations (PDF) |
| 143 | Alzheimer Amyloid-β Peptide Forms Denaturant-Resistant Complex with Type ε3 but Not Type ε4 Isoform of Native Apolipoprotein E | 4.4 | 73 | Citations (PDF) |
| 144 | Metabolism of Alzheimer beta-amyloid precursor protein: regulation by protein kinase A in intact cells and in a cell-free system. | 5.3 | 85 | Citations (PDF) |
| 145 | APOE ε4 IS ASSOCIATED WITH SENILE PLAQUES IN EPILEPSY | 1.5 | 0 | Citations (PDF) |
| 146 | Apolipoprotein E ϵ4 and fatal cerebral amyloid angiopathy associated with dementia pugilistica | 4.7 | 58 | Citations (PDF) |
| 147 | Regulated Formation of Golgi Secretory Vesicles Containing Alzheimer β-Amyloid Precursor Protein (∗) | 1.3 | 156 | Citations (PDF) |
| 148 | NeuroReport | 1.2 | 55 | Citations (PDF) |
| 149 | High levels of amyloid-β protein from S182 (Glu246) familial Alzheimer's cells | 1.2 | 0 | Citations (PDF) |
| 150 | Regulated cleavage of the Alzheimer amyloid precursor protein: Molecular and cellular basis | 2.1 | 31 | Citations (PDF) |
| 151 | Oxygen radical metabolism in vivo: Molecular genetic models and assays | 2.5 | 0 | Citations (PDF) |
| 152 | APP processing, Aβ-amyloidogenesis, and the pathogenesis of Alzheimer's disease | 2.5 | 37 | Citations (PDF) |
| 153 | Targets for Alzheimer's disease research: From basic mechanisms to rational therapies | 2.5 | 0 | Citations (PDF) |
| 154 | Use of Cultured Fibroblasts in Elucidating the Pathophysiology and Diagnosis of Alzheimer's Diseasea | 2.6 | 44 | Citations (PDF) |
| 155 | Serine Phosphorylation of the Secreted Extracellular Domain of APP | 1.5 | 28 | Citations (PDF) |
| 156 | Regulated cleavage of alzheimer β-amyloid precursor protein in the absence of the cytoplasmic tail | 1.8 | 79 | Citations (PDF) |
| 157 | Amyloidogenesis in Alzheimer's disease: some possible therapeutic opportunities | 11.1 | 65 | Citations (PDF) |
| 158 | A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease. | 1.3 | 85 | Citations (PDF) |
| 159 | Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+/calmodulin-dependent protein kinase II. | 5.3 | 215 | Citations (PDF) |
| 160 | Localization of copper-zinc superoxide dismutase in the endocrine pancreas | 2.6 | 15 | Citations (PDF) |
| 161 | Differential downstream signaling in microglia lacking Alzheimer’s-related TREM2 or its adaptor TYROBP/DAP12 | 0.0 | 5 | Citations (PDF) |
| 162 | Real-world clinical profile of individuals with cerebrospinal fluid Aβ-/pTau181. | 1.7 | 0 | Citations (PDF) |
| 163 | Rapid plaque clearance with anti-amyloid therapy for Alzheimer's disease: in consideration of donanemab treatment duration from real-world cases. | 0.2 | 0 | Citations (PDF) |
